Total Funding
35
55
Total FundingGrant raised
Growth Score
-37 pts
Heat Score
-30 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
108550
Orthonika is a pre-clinical spin-out company from Imperial College London developing a novel total meniscus replacement for the knee joint.
- Mario Accardi: Co-FounderPast Role: Orexia, CEO and Co-Founder
About the Company
Meniscus injury can be severely debilitating and may lead to osteoarthritis and the need for knee arthroplasty. Today’s treatment options are limited resulting in a high unmet need. As for example, partial meniscectomy does not restore full joint biomechanics and is thought to lead to knee osteoarthritis. Partial replacement is only suitable as
long as the meniscal rim is intact. Allograft transplantation has severe limitations including donor availability, risk of infection and sizing.
